Healthcare AI Control Plane Evidence Retention | Moring
Evidence retention for a payor control plane means keeping reconstructable production records for every agent action: the identity that acted, the policy evaluated, the data touched, and the approval obtained. Because coverage decisions face scrutiny long after they run, retention has to be scoped per record type and enforced at write time rather than assembled after a request arrives.
Short answer
Evidence retention for a payor control plane means keeping reconstructable production records for every agent action: the identity that acted, the policy evaluated, the data touched, and the approval obtained. Because coverage decisions face scrutiny long after they run, retention has to be scoped per record type and enforced at write time rather than assembled after a request arrives.
How it works
Evidence retention is the control-plane discipline that keeps an agent's history usable after the moment of action. Healthcare agents now pull patient histories from electronic health records, run intake conversations, and summarize clinical context, and Arthur's guidance on governing such agents notes that a generic governance policy will not clear a hospital's compliance review because these systems touch protected health information and act on regulated systems. For payors, the same logic applies with added force: a coverage determination may be examined months or years later, so the record behind it must outlive the operational systems that produced it.
The unit of retention is the reconstructable production record. Fiddler's healthcare governance guidance names continuous monitoring, reconstructable production records, and auditable governance as the loop that closes from evaluation through incidents, and the phrasing is deliberate: a record is evidence only when production behavior can be rebuilt from it. For a payor agent, that means the retained record carries the registered agent identity, the model route, the prompt and response content governed by data classification, the tools invoked, the policy evaluation result, and any human approval, bound to the case identifier that claims and audit staff recognize.
Retention scope needs to be decided per record type, not applied uniformly. Narrative reviews of AI regulation in healthcare, including the PMC analysis of ethical and regulatory challenges in clinical deployment, emphasize that robust governance frameworks must address accountability and legal considerations across the deployment lifecycle, which for payors produces a tiered pattern: determination records and their policy evaluations warrant the longest retention, intermediate model activity sits at a middle tier, and routine lookups take the shortest window. Writing these tiers as control-plane configuration means the enforcement layer applies them automatically at write time instead of relying on periodic cleanup scripts.
Volume makes the tiering consequential. The 2023 breach landscape, with over 167 million Americans impacted by healthcare data breaches according to Censinet's data governance analysis, illustrates how much sensitive material accumulates in healthcare systems, and AI request records concentrate precisely the PHI summaries and clinical context that agents touch. Retaining everything indefinitely expands the breach surface and the review burden; retaining too little destroys the ability to defend a decision. The control plane resolves this tension by classifying each record at creation and attaching its retention clock, so deletion happens by policy rather than by accident.
Ownership and access of retained evidence must be governed too. Spencer Fane's analysis of the healthcare governance gap observes that when AI influences coding, treatment pathways, denials, or consent documentation, the stakes are regulatory, financial, and reputational, which means retained records will be read by parties with different legitimate interests: internal audit, external reviewers, and member dispute processes. Access rules for the evidence store should therefore be as explicit as the retention rules, keyed to role and purpose, so retrieval itself leaves an audit trail.
Frameworks anchor the outer edge of retention obligations. For payors within the EU AI Act's reach, higher-risk systems carry logging and record-keeping duties with defined minimum periods, and payors operating in European markets should treat those periods as the floor their control-plane configuration must meet. The practical standard is simple to state: every consequential agent action produces a record that can be retrieved, reconstructed, and defended for as long as the decision it supported can be questioned.
Frequently asked questions
What counts as evidence in a payor AI control plane?
Evidence is any record from which production behavior can be reconstructed: the agent's registered identity, its model route, the policy evaluation, the tools invoked, the approvals obtained, and the data classifications that governed the request. For healthcare payors these records bind to the case identifier so a specific claim or prior authorization can be traced end to end. A log that shows only what happened without showing which authority permitted it does not meet the standard, because reviewers must be able to prove the action was sanctioned.
How long should payors retain AI decision records?
Retention should be tiered by record type: coverage determinations and their policy evaluations need the longest retention because they can be questioned for years, intermediate model activity an intermediate span, and routine lookups the shortest. EU AI Act logging duties for higher-risk systems set a minimum floor for payors in European scope. The control plane should attach the retention clock at write time so deletion follows policy automatically, avoiding both indefinite accumulation of sensitive records and premature destruction of defensible evidence.
Why is evidence retention harder for payors than for other industries?
Payor agents process protected health information at scale, so their request records concentrate exactly the data whose exposure carries the highest harm, as the breach history of recent years demonstrates. At the same time, coverage determinations remain open to challenge years later, so records cannot simply expire quickly. That combination of maximum sensitivity and maximum hindsight pressure is distinctive to healthcare payors, and it is why retention tiers, access controls on the evidence store, and write-time classification matter more here than in lower-stakes agentic deployments.
Who may access retained AI evidence at a health plan?
Access should be keyed to role and purpose: internal audit and compliance for examinations, clinical and claims leadership for dispute handling, and security teams for incident analysis, with each retrieval itself logged. Because evidence gets read by parties holding different legitimate interests, including external reviewers in dispute processes, the access rules deserve the same explicitness as the retention rules. A payor that leaves evidence-store access open to any operations engineer undermines the defensibility the retention program was built to provide.